| Dr Gregory A. Fielding | |
| 107 S Broadway St, Cleveland, Oklahoma 74020 | |
| (918) 358-2245 |
| Name | Dr Gregory A. Fielding |
|---|---|
| Organization Name | Dr. Gregory A. Fielding Pc |
| Location | 107 S Broadway St, Cleveland, Oklahoma 74020 |
| Type | Supplier |
| Phone | (918) 358-2245 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Now, an international team of researchers from the USA, South Korea and Canada has found that clonal hematopoiesis is tied to the risk of severe COVID-19.
Zoonotic diseases are diseases or infections which are naturally transmissible from animals to humans, as defined in the OIE Terrestrial Animal Health Code.
New two-year data from the Phase 3 ADVANCE clinical trial for peginterferon beta-1a in adults with relapsing forms of multiple sclerosis (RMS) has been presented at the 66th American Academy of Neurology (AAN) annual meeting.
On Target Laboratories Inc., a privately held biotechnology company developing the use of Purdue University-discovered fluorescent markers to target and illuminate cancer during surgery, has announced the results of a multi-institutional Phase 2 clinical trial in which outcomes were improved for 26% of patients undergoing pulmonary resection for non-small-cell lung cancer.
› Verified 7 days ago
News Archive
Now, an international team of researchers from the USA, South Korea and Canada has found that clonal hematopoiesis is tied to the risk of severe COVID-19.
Zoonotic diseases are diseases or infections which are naturally transmissible from animals to humans, as defined in the OIE Terrestrial Animal Health Code.
New two-year data from the Phase 3 ADVANCE clinical trial for peginterferon beta-1a in adults with relapsing forms of multiple sclerosis (RMS) has been presented at the 66th American Academy of Neurology (AAN) annual meeting.
On Target Laboratories Inc., a privately held biotechnology company developing the use of Purdue University-discovered fluorescent markers to target and illuminate cancer during surgery, has announced the results of a multi-institutional Phase 2 clinical trial in which outcomes were improved for 26% of patients undergoing pulmonary resection for non-small-cell lung cancer.
› Verified 7 days ago
Walmart Pharmacy 10-0207 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 772 N Airport Rd, Cleveland, Oklahoma 74020 Phone: (918) 358-5269 | |
Palace Drug Type: Durable Medical Equipment & Medical Supplies Supplier Location: 301n Broadway St, Cleveland, Oklahoma 74020 Phone: (918) 358-2524 | |
Dr Gregory A. Fielding Type: Medicare Supplier Location: 107 S Broadway St, Cleveland, Oklahoma 74020 Phone: (918) 358-2245 |